Practical device to automatically track abnormal retinal blood vessel growth in diabetic eye disease
Official title: Practical device for automated monitoring of neovascularization in diabetic retinopathy
Funded at Fasda INC · NIH-11409917 · Data updated 2026-11-12
A new, easier-to-use imaging device aims to automatically detect and monitor abnormal retinal blood vessel growth in people with diabetic retinopathy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fasda INC NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project start | September 1, 2026 |
| Project end | May 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $292,058 |
| NIH project number | 1R41EY039188-01 |
| Project ID | NIH-11409917 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults aged 21 and older with diabetic retinopathy or at risk for proliferative diabetic retinopathy.
✕Less likely to help
Patients without access to retinal imaging or those without diabetic retinopathy may not benefit directly.
What this research studies
Diabetic retinopathy can cause blindness, and current methods to detect dangerous blood vessel growth are either invasive or not practical for widespread use. This project develops a noninvasive retinal imaging device called R-FASDA that promises high-resolution visualization of retinal vessels at lower cost and simpler operation. If successful, it could help patients gain faster, more accessible monitoring in clinics or nontraditional settings, potentially catching vision-threatening changes earlier. The approach builds on laser speckle imaging to create a broad view of retinal vasculature without the invasiveness of conventional angiography. The study will validate the device against current standards and explore real-world usability.
Why it matters
Potential benefit: If successful, patients could receive earlier detection and monitoring of vision-threatening changes with a cheaper, easier imaging option.
How similar studies have gone: Noninvasive retinal imaging methods exist, but this device aims to combine wide field of view with low cost and ease of use, representing a novel integration.
Where this research is happening
-
Fasda INC
Cambridge, United States Active
Researchers
- Principal investigator: Uribe-Patarroyo, Nestor — Fasda INC
- Study coordinator: Uribe-Patarroyo, Nestor
Related research
Other NIH-funded projects on the same topics.
-
Integrative multi-omics to understand diabetic retinopathy
A doctor-scientist team will study blood markers and genetic signals to see why diabetic retinopathy happens and how it affects Hispanic/Latino people.
-
Smartphone retinal imaging for diabetic eye disease in Egypt
This project uses a low-cost smartphone camera and AI to find signs of diabetic eye damage in adults with diabetes in Egypt.
-
Retinal Cell Loss in Diabetic Retinopathy
This project looks at how mitochondrial problems and a specific kind of cell death called ferroptosis may cause retinal cells to die in people with diabetes-related eye disease.
-
Redox-triggered REDD1 blockers for diabetic retinopathy
A research project tests new ways to stop a stress protein (REDD1) from causing vision problems in people with diabetic retinopathy.
-
Ultrafast eye imaging to detect and track diabetic retinopathy
A doctor-science team is developing ultra-fast eye scans to better see tiny blood vessels in people with diabetic retinopathy, helping catch changes early and guide treatment.
-
Pro/renin receptor signaling and diabetic retinopathy
A diabetes-related eye disease called diabetic retinopathy will be studied to understand how a specific protein pathway contributes to eye damage.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.